Drug Profile
Research programme: orcinol and orcinol derivatives - Kunming Jingbiao Biosciences R & D Co Ltd
Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Kunming Jingbiao Biosciences
- Class Benzene derivatives; Phenols; Small molecules
- Mechanism of Action Brain-derived neurotrophic factor expression stimulants; Hypothalamic hormone modulators; Mitogen-activated protein kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Depressive disorders
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for Depressive disorders in China (PO)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Depressive disorders in China (PO)